-+ 0.00%
-+ 0.00%
-+ 0.00%

Tong Ren Tang announced that Tong Ren Tang Pharmaceutical, a branch of the company, has received a “Product License” approved and issued by the Canadian Ministry of Health, and the product Zuogui Pill has obtained Canadian product registration. The product is a pill. The indications are to nourish the kidneys, improve symptoms related to poor circulation, strengthen bones, and regulate kidney deficiency and osteoporosis. As of the announcement date, Tong Ren Tang Pharmaceutical has invested a total of about 2 million yuan in research and development of the above products. If this product is to be sold in Canada, it is still necessary to complete administrative approval matters such as certification of the Canadian production quality system at the production site. There is uncertainty about the approval, and this approval will not have a significant impact on the company's recent business performance.

Zhitongcaijing·11/16/2026 08:25:23
Listen to the news
Tong Ren Tang announced that Tong Ren Tang Pharmaceutical, a branch of the company, has received a “Product License” approved and issued by the Canadian Ministry of Health, and the product Zuogui Pill has obtained Canadian product registration. The product is a pill. The indications are to nourish the kidneys, improve symptoms related to poor circulation, strengthen bones, and regulate kidney deficiency and osteoporosis. As of the announcement date, Tong Ren Tang Pharmaceutical has invested a total of about 2 million yuan in research and development of the above products. If this product is to be sold in Canada, it is still necessary to complete administrative examination and approval matters such as certification of the Canadian production quality system at the production site. There is uncertainty about the approval, and this approval will not have a significant impact on the company's recent business performance.